4-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)pyridine, 95.0%, 5g

4-Chlorophenyl acetic acid ethyl ester, 95.0%, 25g

Fmoc-D-Gln(Trt)-OH, 96%, 25g

3-(4-Bromophenyl)-isoxazole, 95.0%, 25g

3-Phenylethynyl-benzoic acid, 97.0%, 500mg

4-phenyl-2-hydrophthalazin-1-one, 98%, 95.0%, 100g

4-Bromo-7-hydroxy-2,3-dihydro-1H-inden-1-one, 95.0%, 5g

Methyl 6-fluoro-1H-indazole-3-carboxylate, 95.0%, 2.5g

METHYL N,N-DIMETHYLCARBAMATE, 95%, 250mg

[1,1'-Bi(cyclopropane)]-2-carboxylic acid, 90%, 1g

(R)-(2,3-Dimethoxyphenyl)(1-(4-fluorophenethyl)piperidin-4-yl)methanol, 95.0%, 25mg

1-(2,6-Difluoropyridin-3-yl)ethanone, 97%, 250mg

L-cistina, mínimo 98,5 %, para bioquímica, 500 g, envase de plástico.